Clinical Trials Logo

Childhood ALL clinical trials

View clinical trials related to Childhood ALL.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05858593 Recruiting - Healthy Clinical Trials

Positive Youth Development in the Metaverse

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

This pilot study aims to leverage VR's capacity to easily replicate content and allow for multiple users to share the same space and engage in activities as if they're meeting in person. Integrating VR into afterschool programs will allow youth to receive more consistent programming content, even when they are unable to travel to the physical location for the in-person meetings.

NCT ID: NCT05682131 Recruiting - Childhood ALL Clinical Trials

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

SCCCG-R-ALL
Start date: September 27, 2022
Phase: Phase 4
Study type: Interventional

In recent years, the prognosis of pediatric relapsed ALL patients has improved, but the 5-year OS of patients with first recurrence is still less than 50%. A number of in vitro studies have shown that arsenic trioxide (ATO) can selectively inhibit the growth and induce apoptosis in a variety of leukemia cell lines, suggesting that ATO as a synergist combined with other common chemotherapy drugs may provide a new target for the treatment of relapsed ALL. Realgar Indigo naturalis formula is a compound traditional Chinese medicine preparation developed in China. The main component of realgar is arsenic tetrasulfide (As4S4), which can produce similar pharmacological effects to ATO. Based on the R3 protocol, this study plans to perform a double-blind randomized controlled trial, and to randomly combine compound Huangdai tablets with compound Huangdai tablets in the treatment of intermediate and high risk ALL children, in order to improve the MRD negative rate after induction therapy in this group of children, which may provide a new method for the clinical treatment of relapsed ALL.

NCT ID: NCT05303155 Recruiting - Clinical trials for Coronavirus Infections

The Association of Gut Microbiota With COVID 19 Infection in Children

Start date: April 14, 2022
Phase:
Study type: Observational

Although COVID-19 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. The investigators will analyze the alterations in fecal microbiomes of patients with COVID-19 infection during hospitalization.

NCT ID: NCT04794296 Recruiting - Childhood ALL Clinical Trials

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

LALGFA2019
Start date: November 15, 2021
Phase:
Study type: Observational [Patient Registry]

The LALGFA2019 Recommendations redefine the standard risk criteria and propose to introduce anthracycline induction in so-called high-risk forms (LAL line T and LAL line B with leukocytosis greater than or equal to 50 G/L or in children less than 1 year of age or more than 10 years of age) as well as Endoxan and Methotrexate in high dose consolidation.